tumor immunology

Effects of cellular origin on the development of pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer related deaths mostly due to the absence of symptoms as the cancer develops. This leads to diagnosis after the tumor has already become widely invasive and cannot be surgically removed. Unfortunately, surgical removal of early stage tumors is the most effective treatment option and other treatments, such as chemotherapy, are woefully ineffective.

Thus, there are two major fronts where research could improve the outcomes of pancreatic cancer patients:

Primary Investigator: 
Award Type: 
Year: 
2019
Subscribe to RSS - tumor immunology